2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Francis Knuettel II | CEO | 547,710 | Sep 16, 2024 |
| Balmoral Financial Group LLC | — | 500,078 | Feb 15, 2024 |
| Motif Pharmaceuticals Ltd. | — | 470,674 | Feb 15, 2024 |
| Boswell Prayer Ltd. | — | 459,895 | Feb 15, 2024 |
| Aperture Healthcare Ventures Ltd. | — | 426,566 | Feb 15, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Dec 29, 2025 | Einhorn Andrew J. | Director | Neutral | 90.0 | +12,000 | 100.00% | ✗ | - |
| Dec 29, 2025 | Einhorn Andrew J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 17, 2025 | Dec 19, 2025 | LIGAND PHARMACEUTICALS INC | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Dec 12, 2025 | Pauls Matthew | Director | Neutral | 27.5 | -9,542 | -89.88% | ✗ | - |
| Nov 25, 2025 | Nov 26, 2025 | Friedberg Ezra M | Director | Sell | 20.0 | -10,000 | -7.43% | ✗ | $280.3K |
| Nov 6, 2025 | Nov 10, 2025 | LIGAND PHARMACEUTICALS INC | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 23, 2025 | Plesha Scott M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 23, 2025 | Plesha Scott M. | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 2, 2025 | Jul 21, 2025 | Rangarao Sai | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 21, 2025 | Rangarao Sai | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 2, 2025 | Jul 7, 2025 | Baxter Richard B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Greenleaf Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Pauls Matthew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Francis Knuettel II | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Davis Todd C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Friedberg Ezra M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 2, 2025 | Jul 7, 2025 | Malamut Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 7, 2025 | Greenleaf Peter | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 7, 2025 | Pauls Matthew | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 7, 2025 | Baxter Richard B | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 1, 2025 | Jul 3, 2025 | Friedberg Ezra M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2025 | Jul 3, 2025 | Francis Knuettel II | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2025 | Jul 3, 2025 | Davis Todd C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 11, 2025 | Apr 15, 2025 | Simmons Chia-Lin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 11, 2025 | Apr 15, 2025 | Francis Knuettel II | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 15, 2024 | Davis Todd C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 15, 2024 | Malamut Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 13, 2024 | Nov 15, 2024 | Friedberg Ezra M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 12, 2024 | Sep 16, 2024 | Malamut Richard | Director | Buy | 90.0 | +10,400 | 12.81% | ✗ | $9.8K |
| Sep 12, 2024 | Sep 16, 2024 | Francis Knuettel II | CEO | Buy | 67.5 | +5,200 | 0.96% | ✗ | $5K |
| Sep 10, 2024 | Sep 12, 2024 | Francis Knuettel II | CEO | Buy | 78.8 | +12,000 | 2.26% | ✗ | $11K |
| Jun 28, 2024 | Jul 2, 2024 | Francis Knuettel II | CEO | Neutral | 27.5 | -20,000 | -3.73% | ✗ | - |
| Jul 2, 2024 | Francis Knuettel II | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 21, 2024 | Jun 18, 2024 | Francis Knuettel II | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Simmons Chia-Lin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Lang Eric | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Friedberg Ezra M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Malamut Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Francis Knuettel II | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2024 | Jun 18, 2024 | Davis Todd C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 21, 2024 | Mar 12, 2024 | Friedberg Ezra M | Director | Buy | 87.5 | +16,667 | 3.15% | ✗ | $100K |
| Feb 21, 2024 | Feb 23, 2024 | Francis Knuettel II | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 21, 2024 | Feb 23, 2024 | Davis Todd C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 21, 2024 | Feb 23, 2024 | Friedberg Ezra M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Boswell Prayer Ltd. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Motif Pharmaceuticals Ltd. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Aperture Healthcare Ventures Ltd. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Simmons Chia-Lin | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | AME Equities LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Malamut Richard | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Lang Eric | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Francis Knuettel II | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Friedberg Ezra M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 15, 2024 | Davis Todd C | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |